TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIFOR PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

VIFOR PHARMA

ST13

US500000079158397

Class

3, 5, 35, 39, 41, 42, 45

Filing

79158397

Registration

4948439

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

05/04/2025

Classification

Registered

Trademark type

Combined

Nice classes

3, 5, 35, 39, 41, 42, 45

Filing date

09/18/2014

Registration date

05/03/2016

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2022

Last transaction

05/04/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

CH

Examiner

JUN,WON KYUNG WENDY

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "VIFOR PHARMA". To the left of the wording is a design element of three horizontal straight lines stacked on top of each other.

Holders and representatives

Holders

Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)
Galenica AG

Representatives

Timothy J. Kelly Fitzpatrick, Cella, Harper & Scinto

Technical classification

Nice Classes

Class 3Class 5Class 35Class 39Class 41Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifrices

Class 5

Pharmaceutical preparations for the treatment and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, iron deficiency anemia, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes and related diseases, and migraines and other forms of headache; Pharmaceutical products for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, such as acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, and toxin damage to the kidney; analgesics; antiviral; anti-infectives; anti-inflammatories; antibiotics; antidepressants; anti-cancer preparations; pharmaceutical preparations for use in organ and tissue transplantation; preparations for the treatment of immunologic diseases; pharmaceutical preparations for dialysis and conditions associated with dialysis; preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for treatment of water and electrolyte metabolism disorders and disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; preparations used as immune system stimulators; scabicides; anti-malarials; cough treatment preparations, namely, cough suppressants; preparations for treating coughs and colds; expectorants; anti-leukemic agents; dermatologicals; tissue sealants; vasopressors; pharmaceutical preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; preparations for the treatment of gout; preparations for cessation of smoking; preparations of treatment of Parkinson's disease; vaccines; antiemetics; nasal spray preparations; sanitary preparations for medical uses; parapharmaceutical products for use in dermatology; dietetic foods, namely, dietary supplement; preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teeth; dental wax; all-purpose disinfectants

Class 35

Import agency services in the field of medicines and pharmaceutical preparations; retail store services featuring pharmaceutical and sanitary preparations; import-export agencies in the fields of medicines, pharmaceutical and sanitary preparations

Class 39

Transport, storage, delivery, and packaging of goods, namely, medicines, pharmaceutical and sanitary preparations

Class 41

Business training services as relating to pharmaceutical and sanitary products

Class 42

Research and development of medicines, pharmaceutical preparations and sanitary care products for others

Class 45

Legal services and legal representation of third parties to the authorities and administration with respect to approval of medicines

Publications

History of USPTO decisions and trademark events.

46 publications found

Further Decision Processed by IB

05/03/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/21/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

03/21/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

03/21/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

07/18/2023

C71T

CANCELLED SECTION 71

11/18/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/30/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/13/2018

CHLD

CHANGE OF OWNER RECEIVED FROM IB

10/05/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/17/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/09/2016

FIMP

FINAL DISPOSITION PROCESSED

08/09/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/03/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

05/03/2016

PUBO

PUBLISHED FOR OPPOSITION

02/16/2016

GPNX

NOTIFICATION PROCESSED BY IB

02/12/2016

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/27/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/27/2016

NPUB

NOTICE OF PUBLICATION

01/27/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/13/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

01/11/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/08/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

01/08/2016

CNEA

EXAMINERS AMENDMENT MAILED

01/07/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/07/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/05/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/05/2016

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/05/2016

CNFR

FINAL REFUSAL MAILED

07/09/2015

CNFR

FINAL REFUSAL WRITTEN

07/08/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/09/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/09/2015

ALIE

ASSIGNED TO LIE

06/01/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/27/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/23/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/23/2015

RFNT

REFUSAL PROCESSED BY IB

02/06/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/13/2015

RFRR

REFUSAL PROCESSED BY MPU

01/13/2015

MAFR

APPLICATION FILING RECEIPT MAILED

01/13/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/11/2015

CNRT

NON-FINAL ACTION WRITTEN

01/10/2015

DOCK

ASSIGNED TO EXAMINER

01/08/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2015

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

01/02/2015

Continuous trademark protection

Get notified about every new filing that threatens VIFOR PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.